Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B Nov 19, 2025 09:45AM
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies Jul 8, 2025 08:50AM
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences Jun 11, 2025 08:30AM
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus Jan 22, 2025 08:30AM
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook Dec 26, 2024 09:00AM


Dec 18, 2024 08:45AM Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Sep 20, 2024 09:00AM How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Jun 20, 2024 10:00AM Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Jun 20, 2024 08:45AM Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
May 24, 2024 08:45AM Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
Mar 6, 2024 08:00AM Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
Mar 5, 2024 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
Feb 15, 2024 08:00AM Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
Feb 14, 2024 08:30AM Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
Jan 9, 2024 10:25AM Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Dec 9, 2020 09:30AM Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
Nov 9, 2020 08:11AM Oncolytics Biotech (ONCY) and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at SITC
Nov 9, 2020 08:05AM Oncolytics Biotech® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting
Sep 13, 2013 09:30AM Pre-Open Stock Movers 9/13: (ULTA) (GSVC) (OCLR) Higher; (GALE) (ARTX) (INN) Lower (more...)